References
- Huang JYJ, Rosenwaks Z. Assisted reproductive techniques. In: Rosenwaks Z, Wassarman PM, editors. Human fertility: methods and protocols. New York (NY): Springer; 2014. p. 171–232.
- Merck. GONAL-f 300IU (22 mcg) pen. 2015 [cited 2016 Mar 30]. Available from: https://www.medicines.org.uk/emc/medicine/14383
- Merck. GONAL-f 450 IU (33 mcg) pen. 2015 [cited 2016 Mar 30]. Available from: https://www.medicines.org.uk/emc/medicine/14384
- Merck. GONAL-f 900 IU (66mcg) pen. 2015 [cited 2016 Mar 30]. Available from: https://www.medicines.org.uk/emc/medicine/14385
- Mahony MC, Patterson P, Hayward B, et al. Human factors engineering and design validation for the redesigned follitropin alfa pen injection device. Expert Opin Drug Deliv. 2015;12:715–725.
- Abbotts C, Salgado-Braga C, Audibert-Gros C. A redesigned follitropin alfa pen injector for infertility: results of a market research study. Patient Prefer Adherence. 2011;5:315–331. Epub 2011 Jul 28.
- Kivitz A, Cohen S, Dowd JE, et al. Clinical assessment of pain, tolerability, and preference of an autoinjection pen versus a prefilled syringe for patient self-administration of the fully human, monoclonal antibody adalimumab: the TOUCH trial. Clin Ther. 2006;28:1619–1629. Epub 2006 Dec 13.
- Christen M, Schertz JC, Arriagada P, et al. The redesigned follitropin α pen injector for infertility treatment. Expert Opin Drug Deliv. 2011;8:833–839.
- Schertz JC, Saunders H, Hecker C, et al. The redesigned follitropin alfa pen injector: results of the patient and nurse human factors usability testing. Expert Opin Drug Deliv. 2011;8:1111–1120.
- Jeannerot F, Stüdeli T, Gunther-LaVergne L, et al. Usability engineering study in the European Union of a redesigned follitropin alfa pen injector for infertility treatment. Expert Opin Drug Deliv. 2016;13:1221–1229. Epub 2016 Jun 23.
- U.S. Food and Drug Administration. What to do if you can’t find a sharps disposal container. 2014 [cited 2016 Apr 7]. Available from: http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/HomeHealthandConsumer/ConsumerProducts/Sharps/ucm263259.htm
- IEC/ISO. ISO 11608-2:2012 needle-based injection systems for medical use – requirements and test methods – part 2: needles. Geneva: IEC/ISO; 2012.
- IEC/ISO. ISO 11608-3:2012: needle-based injection systems for medical use – requirements and test methods – part 3: finished containers. Geneva: IEC/ISO; 2012.
- IEC/ISO. ISO 11608-1:2014 needle-based injection systems for medical use – requirements and test methods – part 1: needle-based injection systems. Geneva: IEC/ISO; 2014.
- Friedrichs A, Bohnet J, Korger V, et al. Dose accuracy and injection force of different insulin glargine pens. J Diabetes Sci Technol. 2013;7:1346–1353. Epub 2013 Oct 16.
- LaRue S, Malloy J. Evaluation of the dual-chamber pen design for the injection of exenatide once weekly for the treatment of type 2 diabetes. J Diabetes Sci Technol. 2015;9:815–821. Epub 2015 Mar 12.
- IEC/ISO. ISO 11608-1:2012 needle-based injection systems for medical use – requirements and test methods – part 1: needle-based injection systems. Geneva: IEC/ISO; 2012.
- Pfützner A, Asakura T, Sommavilla B, et al. Insulin delivery with FlexPen: dose accuracy, patient preference and adherence. Expert Opin Drug Deliv. 2008;5:915–925. Epub 2008 Aug 21.
- Martin JM, Llewelyn JA, Ristic S, et al. Acceptability and safety of a new 3.0 ml re-usable insulin pen (HumaPen) in clinical use. Diabetes Nutr Metab. 1999;12:306–309. Epub 2000 Mar 31.
- IEC/ISO. IEC 62366-1:2015 medical devices – part 1: application of usability engineering to medical devices. Geneva: IEC/ISO; 2015.
- IEC/ISO. IEC/DTR 62366-2 (draft) medical devices. Geneva: IEC/ISO; 2016.
- European Medicines Agency. Good practice guide on risk minimisation and prevention of medication errors. 2015 Nov 18 [cited 2016 Mar 30]. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Regulatory_and_procedural_guideline/2015/04/WC500185538.pdf
- United States Food and Drug Administration. Guidance for industry and food and drug administration staff: applying human factors and usability engineering to medical devices. 2016 Feb 3 [cited 2016 Mar 29]. Available from: http://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/ucm259760.pdf